Molecular Cloning and Expression of EG95 Gene of Iranian Isolates of Echinococcus granulosus
,
Abstract
Background: Echinococcosis or hydatidosis is a chronic, zoonotic worldwide infection that occurs by the larval stages of taeniid cestodes of the genus Echinococcus. Iran is known as endemic region for this infection in the world. Vaccination has been considered as a good prevention method for this disease. Recombinant vaccines containing EG95 protein, against E. granulosus, has shown a high degree of protection against E. granulosus infection. In this study EG95 gene was extracted from Iranian isolates of E. granulosus and then cloned and expressed in expression vector.
Methods: Protoscoleces were collected from sheep hydatid cysts. Then DNA and RNA were extracted from protoscoleces, and amplified by PCR and RT-PCR with specific primer. Afterward the purified RT-PCR products were successfully ligated into pTZ57R/T plasmid vector. The pcDNA3 plasmid was used as expression vector and Eg95 fragment sub cloned into this plasmid. The pcEG95 plasmid was digested by restriction enzymes to confirm cloning of this gene in pcDNA3 plasmid. In last step, the subcloned gene was expressed in CHO as eukaryotic cell.
Results: EG95 fragment successfully was subcloned in pcDNA3 and EG95 protein was expressed by eukaryotic cell. The recombinant EG95 protein was confirmed by SDS-PAGE and Western blot.
Conclusion: Recombinant plasmid of pcEG95 was constructed successfully and express of recombinant EG95 protein was confirmed.
Moro P, Schantz PM. Echinococcosis: a review. Int J InfectDis. 2009;13(2):125-33.
Hemphill A, Kern P. Special issue: Experimental studies in echinococcosis. Exp Parasitol. 2008; 119: 437–438.
Dalimi A, Motamedi Gh, Hosseini M, Mohammadian B, Malaki H, Ghamari Z, Ghaffari-far F. Echinococcosis / hydatidosis in western Iran. Vet Parasitol. 2002; 105(2): 161-171.
Rokni MB. Echinococcosis /hydatidosis in Iran. Iranian J Parasitol. 2009; 4(2): 1-16.
Moulazadeh P, Zohoor A. Prevalence of liver trematodes and hydatid cyst in Jiroft abattoir livestock. JSSU. 2004; 12(1):10-14.
Daryani A, Alaei R, Arab R, Sharif M, Dehghan MH, Ziaei H. The prevalence, intensity and viability of hydatid cysts in slaughtered animals in the Ardabil Province of Northwest Iran. J Helminthol. 2007;81:13-17.
Lightowlers MW, Lawrence SB, Gauci CG, Young J, Ralston MJ, Maas D, Health DD. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol. 1996; 18:457–62.
Zhang W, McManus D. Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease? Trends Parasitol. 2008; 24 (9): 419-424.
Gauci C, Heath D, Chow C, LightowlersMW. Hydatid disease: vaccinology and development of the EG95 recombinant vaccine. Expert RevVaccines. 2005; 4 (1):103–112.
Lightowlers MW, Jensen O, Fernandez E, Iriarte JA, Woollard DJ, Gauci CG, JenkinsDJ, Heath DD. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Inter J Parasitol. 1999; 29(4): 531-534.
Paykari H,Heath DD,Dalimi A, Karimi GhR,Motemedi GhR. Experimental vaccination of sheep against hydatid cyst using EG95 recombinant vaccine. Arch Razi Institute, 2008; 63(1): 29-34.
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual, (2nd ed) Cold Spring HarborLaboratory Press; 2001.
McManus DP, Zhang W, Li J, Bartley PB.Echinococcosis. Lancet. 2003; 362(9392). 1295-304.
Gemmell MA. Immunological responses ofthe mammalian host against tapeworm infections IV. Species specificity of hexacanth embryo in protecting sheep against Echinococcus granulosus. Immunology. 1966; 11:325–335.
Heath DD, Parmeter SN, Osborn PJ, Lawrence SB. Resistance to Echinococcus granulosus infection in lambs. J Parasitol. 1981; 67: 797–799.
Osborne PJ, Heath DD. Immunity of lambs against Echinococcus granulosus using antigens obtained by incubation of oncospheres in vitro. ResVet Sci. 1982; 33: 132– 133.
Heath DD, Lawrence SB. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules. Parasite Immunol. 1996; 18: 347–357.
Lin RY,Ding JB,Wen H. Cloning, homological analysis and construction of EG95 Xinjiang strain DNA vaccine. Hepatobiliary PancreatDis Int. 2003; 2(4): 545-48.
Zhang W, Li J, You H, Zhang Z, Turson G, Loukas A,McManusDP. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAs encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere. Am J Trop Med Hyg. 2003; 68: 40-43.
Chow C, Gauci C, Cowman AF, LightowlersMW. A gene family expressing a hostprotective antigen of Echinococcus granulosus. Mol BiochemParasitol. 2001; 118:83–88.
Scheerlinck JPY, Casey G, McWaters P, Kelly J,Woollard D, LightowlersMW, Tennent JM, Chaplin PJ. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime protein boost strategy.Vaccine. 2001; 19: 4053–4060.
Heath DD, Holcman B, Shaw RJ. Echinococcus granulosus: the mechanism of oncosphere lysis by sheep complement and antibody. Int J Parasitol 1994;24(7):929–35.
| Files | ||
| Issue | Vol 7 No 2 (2012) | |
| Section | Articles | |
| Keywords | ||
| Echinococcus granulosus EG95 pcDNA3 plasmid | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
